Published in
BMJ Publishing Group, Journal for ImmunoTherapy of Cancer, 1(6), 2018
DOI: 10.1186/s40425-018-0432-9
Links
Tools
CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells
Journal article published in 2018 by
Regina Jitschin,
Domenica Saul,
Martina Braun,
Sehmus Tohumeken,
Simon Völkl,
Roman Kischel,
Michael Lutteropp,
Cedric Dos Santos,
Andreas Mackensen,
Dimitrios Mougiakakos 
This paper is made freely available by the publisher.
Full text: Download
Data provided by 